Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/06/2012US20120225821 Composition for preventing or treating a spinal cord injury
09/06/2012US20120225820 Peptides associated with hla-dr mhc class ii molecule and involved in rheumatoid arthritis
09/06/2012US20120225819 Stable formulation of factor viii
09/06/2012US20120225818 Plasma protein effective for suppressing cough
09/06/2012US20120225817 Therapeutic agent for gastrointestinal disease
09/06/2012US20120225816 Pharmaceutical Compositions of Melanocortin Receptor Ligands
09/06/2012US20120225815 Novel Cellular Factor-Containing Solution Compositions
09/06/2012US20120225814 Hydrogel-based vascular lineage cell growth media and uses thereof
09/06/2012US20120225813 Compositions, methods and uses for treatment of type 1 diabetes
09/06/2012US20120225812 Substituted fused pyrimidine compounds, its preparation and uses thereof
09/06/2012US20120225811 Insulin analogues
09/06/2012US20120225810 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
09/06/2012US20120225809 Compounds for treating papilloma virus infection
09/06/2012US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient
09/06/2012US20120225807 Bacterial membrane protein secretion
09/06/2012US20120225482 Mammalian cx3c chemokine antibodies
09/06/2012US20120225143 Cold sore formulation and related method of manufacture
09/06/2012US20120225134 Methods and compositions for the treatment and prevention of hypoglycemia and related disorders
09/06/2012US20120225128 Method for carrying therapeutic substances into cells
09/06/2012US20120225118 Compositions for delivery of insoluble agents
09/06/2012US20120225114 Modifying Macrophage Phenotype for Treatment of Disease
09/06/2012US20120225107 Stable skin and scar treatment composition
09/06/2012US20120225101 Multifunctional in situ polymerized network via thiol-ene and thiol-maleimide chemistry
09/06/2012US20120225099 Compositions for and methods of activating guanylyl cyclase c
09/06/2012US20120225089 Novel conjugates, preparation thereof, and therapeutic use thereof
09/06/2012US20120225084 Klf family members regulate intrinsic axon regeneration ability
09/06/2012US20120225083 Viral polypeptides and methods
09/06/2012US20120225082 ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
09/06/2012US20120225078 Immune system modulating composition
09/06/2012US20120225077 Novel molecules of the card-related protein family and uses thereof
09/06/2012US20120225073 Isolation and Use of Melanoma Cancer Stem Cells
09/06/2012US20120225059 Novel Agents and Uses Thereof
09/06/2012US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
09/06/2012US20120225053 Compositions and methods for the prevention and treatment of conditions associated with inflamation
09/06/2012US20120225052 Composition and method for treating tissue defects
09/06/2012US20120225051 Tissue kallikrein for the treatment of huntington's disease
09/06/2012US20120225050 Methods for improving gut health
09/06/2012US20120225049 Fast acting snare-cleaving enzymes
09/06/2012US20120225048 Novel Cellular Factor-Containing Solution Compositions
09/06/2012US20120225047 Nutrigenetic biomarkers for obesity and type 2 diabetes
09/06/2012US20120225046 Variant form of urate oxidase and use thereof
09/06/2012US20120225041 Methods and compositions for treating tissue using silk proteins
09/06/2012US20120225033 Biodegradable Drug Delivery Composition
09/06/2012US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/06/2012US20120225031 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
09/06/2012US20120225030 Uses of mammalian cytokine; related reagents
09/06/2012US20120225029 Skin Cream
09/06/2012US20120225028 Compositions and methods for mobilization of stem cells
09/06/2012US20120225023 Peptide protection against ultraviolet light toxicity
09/06/2012US20120225021 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
09/06/2012US20120225012 Composition for hard tissue repair
09/06/2012US20120225011 Glassy compositions
09/05/2012EP2495327A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/05/2012EP2495324A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
09/05/2012EP2495315A1 Humanized recombinant uricase and mutants thereof
09/05/2012EP2495255A1 Glycosylated form of antigenic glp-1 analogue
09/05/2012EP2495252A2 Soluble forms of hendra and nipah virus G glycoprotein
09/05/2012EP2495251A1 Hydrochloride salts of a glycopeptide phosphonate derivative
09/05/2012EP2495250A2 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
09/05/2012EP2495249A1 Tertiary amine substituted peptides useful as inhibitors of HCV replication
09/05/2012EP2494983A1 Stable formulations of GLP-1
09/05/2012EP2494982A1 Method of treating pulmonary disease with interferons
09/05/2012EP2494981A1 Use of interleukin-1 receptor antagonist for preparing medicament for preventing or treating epithelium trauma of intestinal mucosa
09/05/2012EP2494980A2 Medical utility of glycans
09/05/2012EP2494977A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
09/05/2012EP2494958A1 Amphiphilic Entity Nanoparticles
09/05/2012EP2494040A1 Method of producing recombinant vitamin k dependent proteins
09/05/2012EP2493918A2 Improved neurturin molecules
09/05/2012EP2493910A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
09/05/2012EP2493572A1 Angiogenesis promoted by caged growth factors
09/05/2012EP2493497A2 Notch inhibition in the treatment and prevention of obesity and metabolic syndrome
09/05/2012EP2493496A1 Use of gstp1
09/05/2012EP2493495A2 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
09/05/2012EP2493494A2 Methods and kits for preventing hypoglycemia
09/05/2012EP2493493A1 New bacitracin antibiotics
09/05/2012EP2493492A1 Phosphorylated twist1 and cancer
09/05/2012EP2493489A1 Method for treating acidosis in ruminants
09/05/2012EP2493487A1 Composition to induce specific immune tolerance
09/05/2012EP2493470A1 Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin
09/05/2012EP2493453A1 Use of biocompatible compositions and materials polymerized therefrom for inhibiting angiogenesis
09/05/2012EP2493336A1 Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
09/05/2012EP2493295A1 Methods to mitigate injury from radiation exposure
09/05/2012CN1970746B Bifunctional variants of recombinant tissue-type plasminogen activator with platelet aggregation inhibitory activity
09/05/2012CN1961001B Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
09/05/2012CN1956994B Epithelial cell growth promoter
09/05/2012CN1925866B Treatment of bacterial infections
09/05/2012CN1905897B Antagonist anti-CD40 monoclonal antibodies and methods for their use
09/05/2012CN1896231B Method for separating tetramer uric acid oxydiazing enzyme
09/05/2012CN1679934B Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
09/05/2012CN1639569B Methods and compositions for inducing an immune response
09/05/2012CN1592791B Phytases, nucleic acids encoding them and methods for making and using them
09/05/2012CN1535724B New application of recombinant human interferon for preventing serious acute respiratory tract syndrome
09/05/2012CN102656266A Chimeric fibroblast growth factors with altered receptor specificity
09/05/2012CN102656189A Antibodies against human respiratory syncytial virus (RSV) and methods of use
09/05/2012CN102656188A T-cell receptor capable of recognising an antigen from cytomegalovirus
09/05/2012CN102656187A Truncated ActRIIB-FC fusion proteins
09/05/2012CN102656186A Therapeutic agents
09/05/2012CN102656183A 催产素受体激动剂 Oxytocin receptor agonist
09/05/2012CN102655877A FGF21 mutants and uses thereof
09/05/2012CN102655876A Composition, method, and kit for alpha-1 proteinase inhibitor
1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 3163